Today’s Research Reports on Trending Tickers: Exelixis and Zafgen
NEW YORK, NY / ACESSWIRE / June 26, 2018 / U.S. equities plunged on Monday, as indexes posted their biggest one-day decline in week, as fresh threats from President Trump added to the uncertainties of a potential trade war. The S&P 500 Index shed 1.37 percent to close at 2,717.07, while the Nasdaq Composite dropped 2.09 percent to close at 7,532.01. The Dow Jones Industrial Average declined 1.33 percent to settle at 24,252.80, its lowest close since May 4.
“You can now make the case that we’re in a trade war. The language has gotten bad enough, companies are saying the issue is impacting them, and there’s a sense that the numbers and scope of the issue are ratcheting up,” said Willie Delwiche, investment strategist at Robert W. Baird.
RDI Initiates Coverage on:
Exelixis, Inc.
https://rdinvesting.com/news/?ticker=EXEL
Zafgen, Inc.
https://rdinvesting.com/news/?ticker=ZFGN
Exelixis’ stock moved 2.5% lower Monday, to close the day at $19.54. The stock recorded a trading volume of 1,966,879 shares, which was below its three months average volume of 3,619,617 shares. In the last year, Exelixis’ shares have traded in a range of 18.50 – 32.50. The share price has gained 5.62% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $20.34 is below its 200-day moving average of $24.64. Shares of the company are trading at a Price to Earnings ratio of 24.15. Shares of Exelixis have fallen roughly 6.24 percent in the past month and are down 35.72 percent year-to-date.
Access RDI’s Exelixis, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=EXEL
On Monday, shares of Zafgen recorded a trading volume of 2,084,899 shares, which was above the three months average volume of 145,228 shares. The stock ended the day 26.8% higher at $8.99. The share price has fallen 10.1% from its 52 week high with a 52 week trading range of 3.21 – 10.00. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $6.81 is above its 200-day moving average of $6.64. Shares of Zafgen have gained roughly 45.23 percent in the past month and are up 94.59 percent year-to-date.
Access RDI’s Zafgen, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ZFGN
Our Actionable Research on Exelixis, Inc. (NASDAQ:EXEL) and Zafgen, Inc. (NASDAQ:ZFGN) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
ReleaseID: 503762